India is about to destroy Ozempic monopoly #glp1 #ozempic #semaglutide #pharmastock

On March 21, 2026, the GLP-1 "Patent Cliff" hits India, and a $100 Billion gold rush begins. While the world watches Ozempic and Wegovy, the real multi-bagger opportunities are hidden in the Indian supply chain—from API makers to auto-injector disruptors.
In the linked deep dive, we trace the entire life cycle of the GLP-1 molecule from lab to patient. We aren't just looking at the big names; we are identifying the "picks and shovels" of this industry—the companies making the peptides, the pens, and the cold-chain logistics that make this miracle drug possible.

I’m Avani, and on "The Next Big Thing," we hunt for long-term investment themes before they become mainstream news. We just hit 500 subscribers—help us reach our goal of 5,000 serious investors by June 2026! 🚀
🔔 Subscribe for more deep dives into the future of wealth

Disclaimer: Nothing in this video is investment advice. These are my personal research views and opinions. Always do your own due diligence before investing your hard-earned money.

#drreddys #cipla #biocon #onesource #shailyengineering #glandpharma #sunpharma #shilpamedicare #jubilantpharmova #syngeneinternational #elililly #novonordisk #divislaboratries #neulandlaboratries

#GLP1 #Ozempic #IndianStockMarket #Investing #WealthBuilding #TheNext BigThing #2026Investing #PharmaStocks #Nifty50

Видео India is about to destroy Ozempic monopoly #glp1 #ozempic #semaglutide #pharmastock канала Next Big Thing*